SEC Form 4 · accession 0002031182-26-000003
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Aaron Rosenberg
Officer — Chief Financial Officer
Period of report
Jun 11, 2026
Accepted (ET)
Jun 15, 2026 · 5:55 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary SharesF1 | Jun 11, 2026 | A | 71,175 | $0.00 | A | 397,891 | D | |
| American Depositary SharesF2,F4 | Jun 11, 2026 | S | 631 | $257.7441 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Share Option (Right to Buy)F5,F6 | $20.81 | Jun 11, 2026 | A | 137,865 | A | — | Jun 10, 2036 | Ordinary Shares | 137,865 | 137,865 | D |
Explanation of responses
- F1Represents securities underlying restricted share units. 1/4th of the securities will vest on each anniversary of June 11, 2026, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F2Each American Depositary Share represents 13 Ordinary Shares.
- F3The sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person. 1/4th of the securities will vest on each anniversary of June 10, 2025, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $257.3392 to $257.765, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
- F5The number of securities underlying each option and the exercise price therefor are represented in ordinary shares.
- F6These securities vest over a four-year period as follows: 25% on the first anniversary of June 11, 2026 with the remaining shares vesting in 36 equal successive monthly installments thereafter, subject to continued service. Unvested securities are subject to accelerated vesting upon certain termination events.